Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul;9(7):895-903.
doi: 10.1002/biot.201300074.

Preserving human cells for regenerative, reproductive, and transfusion medicine

Affiliations
Review

Preserving human cells for regenerative, reproductive, and transfusion medicine

Waseem Asghar et al. Biotechnol J. 2014 Jul.

Abstract

Cell cryopreservation maintains cellular life at sub-zero temperatures by slowing down biochemical processes. Various cell types are routinely cryopreserved in modern reproductive, regenerative, and transfusion medicine. Current cell cryopreservation methods involve freezing (slow/rapid) or vitrifying cells in the presence of a cryoprotective agent (CPA). Although these methods are clinically utilized, cryo-injury due to ice crystals, osmotic shock, and CPA toxicity cause loss of cell viability and function. Recent approaches using minimum volume vitrification provide alternatives to the conventional cryopreservation methods. Minimum volume vitrification provides ultra-high cooling and rewarming rates that enable preserving cells without ice crystal formation. Herein, we review recent advances in cell cryopreservation technology and provide examples of techniques that are utilized in oocyte, stem cell, and red blood cell cryopreservation.

Keywords: Cryopreservation; Regenerative medicine; Reproductive medicine; Transfusion medicine; Vitrification.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement

Dr. Utkan Demirci is a founder of, and has an equity interest in: (i) DxNow Inc., a company that is developing microfluidic and imaging technologies for point-of-care diagnostic solutions, and (ii) Koek Biotech, a company that is developing microfluidic IVF technologies for clinical solutions. Dr. Utkan Demirci’s interests were viewed and managed by the Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies.

Figures

Figure 1
Figure 1
Minimum volume vitrification methods. (A) An image of closed-pull straw system. (B) Magnified image of straw with oocytes loaded inside. The straw diameter is 200 μm. (C) Image of a viable oocyte just after warming (T1 stage). (D) Image of a viable oocyte 4 hours after warming (T4 stage), just before intracytoplasmic sperm injection. (E) Image of a Day 3 human embryo at 6 cell grade 2 stage. (F) Sonogram showing a ten week clinical pregnancy following a transfer of 3 embryos. A–F are reprinted by copyright permissions from [41]. (G) Cryoloop carrier loaded 4 human oocytes. (H) Cryotop carrier loaded with 5 oocytes. Scale bars indicate 400 μm. G and H are reprinted by copyright permissions from [108].
Figure 2
Figure 2
(A) Surface-based vitrification method. (i) A modification of Thermanox cultivation disc with a small tip to handle with tweezer. (ii) Disc incubation in CPA. Multi photon laser scanning micrographs of hESC-colonies (iii) Control colony, (iv) Cryopreserved colony using slow rate freezing, and (v) Cryopreserved colony using surface based vitrification. Fewer membrane vesicles (arrows) were observed in vitrified sample. Scale bars indicate 100 μm. Reprinted by copyright permissions from [80]. (B) Bulk vitrification method. hESC cell clumps were loaded on the nylon mesh of a cell strainer and incubated in CPA. The inset (right) shows the magnified view of nylon mesh with cell clumps indicated by arrows. Reprinted by copyright permissions from [81].

Similar articles

Cited by

References

    1. Deller RC, Vatish M, Mitchell DA, Gibson MI. Synthetic polymers enable non-vitreous cellular cryopreservation by reducing ice crystal growth during thawing. Nature communications. 2014;5:3244. - PubMed
    1. Tao T, Del Valle A. Human oocyte and ovarian tissue cryopreservation and its application. Journal of assisted reproduction and genetics. 2008;25:287–296. - PMC - PubMed
    1. Agca Y. Cryopreservation of oocyte and ovarian tissue. ILAR J. 2000;41:207–220. - PubMed
    1. Hanna J, Hubel A. Preservation of stem cells. Organogenesis. 2009;5:134–137. - PMC - PubMed
    1. Malgieri A, Kantzari E, Patrizi MP, Gambardella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med. 2010;3:248–269. - PMC - PubMed

Publication types

Substances